Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global Orphan Drugs Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. United States market for Orphan Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 ... Read More
-
Asthma - Market Insight, Epidemiology and Market Forecast -2032
... trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Asthma market report provides current treatment practices, emerging drugs, Asthma market share of the individual therapies, current and forecasted ... Read More
-
Epigenetic Therapeutics: Global Markets
... product type, the market is segmented into PRAP inhibitors, Kinase inhibitors, IDH inhibitors, HDAC inhibitors, DNMT inhibitors and KMT inhibitors. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific, and the ... Read More
-
Chemotherapy-induced peripheral neuropathy - Epidemiology Forecast - 2032
... leads to dose reduction or discontinuation of treatment and decreases the quality of life of cancer survivors. Chemotherapy-induced peripheral neuropathy presents clinically as sensory, motor, and sometimes autonomic function deficits. Sensory disturbances range from mild ... Read More
-
Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2032
... Esophageal cancer, also known as esophagus cancer, develops in the cells that line the esophagus and occurs when a malignant tumor arises in the esophagus lining. In 2022, the market size of Esophageal Cancer (EC) ... Read More
-
Chemotherapy-induced Peripheral Neuropathy - Market Insight, Epidemiology And Market Forecast - 2032
... such as bortezomib. It not only leads to dose reduction or discontinuation of treatment but also decreases the quality of life of cancer survivors. In 2022, the market size of chemotherapy-induced peripheral neuropathy was highest ... Read More
-
Persistent Epithelial Defect (PEDs) - Market Insight, Epidemiology and Market Forecast -2032
... and forecasted epidemiology as well as the Persistent Epithelial Defect (PEDs) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Persistent Epithelial Defect (PEDs) market report provides ... Read More
-
Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS)-inhibitors – Market Insights, Epidemiology and Market Forecast – 2032
... and Europe In the United States, KRASG12C is present in ~37% of NSCLC cases. The highest rates of KRASG12D, i.e., ~42% and 30%, were found in pancreatic cancer and CRC, respectively Among the approved therapies, ... Read More
-
Bullous Keratopathy—Market Insights, Epidemiology, and Market Forecast—2032
... trends in the United States, the EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. The Bullous Keratopathy market report provides current treatment practices, emerging drugs, Bullous Keratopathy market share of the individual ... Read More
-
Glaucoma Market Insight, Epidemiology And Market Forecast - 2032
... estimated to be nearly 17 million (Prevalent cases) in 2022 in the 7MM. Most diagnosed Glaucoma patients were estimated in the US, followed by Japan, Germany, and France in 2022. Open Angle Glaucoma is most ... Read More
-
Allergy Immunotherapy Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Significant advancements in allergy immunotherapy techniques have propelled the industry ... Read More
-
Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) - Global Forecasts to 2028
... to reach USD 72.9 billion by 2028 from 36.8 billion in 2023, at a CAGR of 14.6% during the forecast period. Factors such as increasing government funding for R&D projects to develop new therapeutics and ... Read More
-
Organoids Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells), and Geography
... Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells), and Geography The organoids market is expected to grow from US$ 2.50 billion in 2022 to US$ ... Read More
-
Dyslipidemia Epidemiology Analysis and Forecast to 2032
... Dyslipidemia is a major risk factor for the development of cardiovascular disease, including heart attack and stroke. Lipids, such as cholesterol or TGs, are absorbed from the intestines and are carried throughout the body via ... Read More
-
Gastrointestinal Drugs Market Covering Antacids; Antiulcerants; Antiemetics And Antinauseants; Antidiarrhoeals; Global Summary 2023
... In terms of per capita consumption, the market was $9.7 and in terms of global GDP, the market was 0.07%. Gastrointestinal drugs was the eighth largest segment within the market accounting for 4.7% preceded and ... Read More
-
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... prevalent cases of narcolepsy in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. The majority of marketed drugs for the treatment of narcolepsy are transport inhibitors and receptor agonists. The narcolepsy pipeline consists ... Read More
-
Dermatology Drugs Market Covering Acne; Dermatitis; Psoriasis; Alopecia; Global Summary 2023
... of per capita consumption, the market was $7.1 and in terms of global GDP, the market was 0.05%. Dermatology drugs was the tenth largest segment within the market accounting for 3.4% preceded and followed by ... Read More
-
Global HIV Treatment Market: Analysis By Product (Atripla, Biktarvy, Descovy, Genovya, Odefsey, Truvada, Sunlenca (Lenacapavir), Dovato, Juluca, Tivicay, Triumeq, Cabenuva, VH184, Capsid, bNAbs, Islatravir, and Generics), By Region (The US, and EU + ROW) Size and Trends with Impact of COVID-19 and Forecast up to 2030
... and Trends with Impact of COVID-19 and Forecast up to 2030 The global HIV treatment market in 2022 stood at US$22.38 billion, and is likely to reach US$25.49 billion by 2030. HIV treatment, also known ... Read More
-
Global Pulmonary Arterial Hypertension (PAH) Market: Analysis By Drug Class (Prostacyclin and Prostacyclin Analogs, Endothelin Receptor Antagonists (ERAs), sGC Stimulators, and pde-5 Inhibitors), By Type (Branded and Generic), By Route of Administration (Oral, Intravenous/ Subcutaneous, and Inhalation), By Distribution Channel (Hospital Pharmacies and Clinic, Retail Pharmacies, and Online Pharmacies), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
... and Inhalation), By Distribution Channel (Hospital Pharmacies and Clinic, Retail Pharmacies, and Online Pharmacies), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028 The global pulmonary arterial hypertension market was ... Read More
-
Cardiovascular Drugs Market Covering Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Angina Pectoris; Congestive Heart Failure; Other Drugs For Cardiovascular Diseases (Anti-Arrhythmic And Anti-Anginal Drugs); Global Summary 2023
... 2022. It was the fifth largest segment within the market accounting for 9.6%. In terms of per capita consumption, the market was $19.8 and in terms of global GDP, the market was 0.14%. Cardiovascular drugs ... Read More
-
Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 344 million prevalent cases of CLBP in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. Chronic pain continues to be a significant global burden despite the availability of a variety of ... Read More
-
Alzheimer’s Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030
... UK, Japan, China) and provides an Excel-based forecast model for the Alzheimer's disease market through 2030. Alzheimer's Disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. ... Read More
-
Rhabdomyosarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Rhabdomyosarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Rhabdomyosarcoma. Report includes ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report provides top line data ... Read More
-
Antihyperlipidemic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 16.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.6% during 2023-2028. Antihyperlipidemic drugs help lower serum levels of cholesterol and various lipids in the blood. They can be taken with different ... Read More
Research Assistance
